
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
Huijberts, Sanne C. F. A., van Geel, Robin M. J. M., van Brummelen, Emilie M. J., Opdam, Frans L., Marchetti, Serena, Steeghs, Neeltje, Pulleman, Saskia, Thijssen, Bas, Rosing, Hilde, Monkhorst, Kim,Volume:
85
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-020-04066-4
Date:
May, 2020
Fichier:
PDF, 1.66 MB
2020